Camber Launches Generic Ofirmev®

Piscataway, NJ, July 25, 2024 – Camber Pharmaceuticals is pleased to announce the addition of Acetaminophen Injection to its product line.
Acetaminophen Injection is indicated for:
- Management of mild to moderate pain in adult and pediatric patients 2 years and older
- Management of moderate to severe pain with adjunctive opioid analgesics in adult and pediatric patients 2 years and older
- Reduction of fever in adult and pediatric patients
Acetaminophen Injection is available in 1000mg/100ml (10mg/ml) strength in either 10 or 24 packs of 100 mL single dose vials.
To learn more about Acetaminophen Injection, please visit https://www.camberpharma.com/acetaminophen
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection